Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Conditions
Anatomic Stage IV Breast Cancer AJCC v8 · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Locally Advanced Malignant Solid Neoplasm · Locally Advanced Melanoma · Locally Advanced Primary Malignant Central Nervous System Neoplasm · Locally Advanced Sarcoma · Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Metastatic Primary Malignant Central Nervous System Neoplasm · Metastatic Sarcoma · Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Prognostic Stage IV Breast Cancer AJCC v8 · Stage IIIC Colorectal Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Colorectal Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8 · Stage IVA Colorectal Cancer AJCC v8 · Stage IVA Lung Cancer AJCC v8 · Stage IVB Colorectal Cancer AJCC v8 · Stage IVB Lung Cancer AJCC v8 · Stage IVC Colorectal Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jordi Rodon Ahnert)
Study leads
Jordi Rodon Ahnert
Principal Investigator
M.D. Anderson Cancer Center